Citations 1

Circulating Tumor DNA As a Biomarker for Molecular Residual Disease Assessment in Patients with Diffuse Large B-Cell Lymphoma

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 11884-11886

10.1182/blood-2022-169656